Promising results achieved in phase II study of thalidomide in multiple myeloma Sep. 6, 1999 No Comments
Synthesis and mechanism of action of a natural compound acting on a previously undefined target Sep. 3, 1999 No Comments
Potent protein farnesyltransferase inhibitors emerge from Parke-Davis program Sep. 3, 1999 No Comments
Licensing opportunity from NIH: geldanamycins as inhibitors of the HGF/SF-Met pathway Sep. 3, 1999 No Comments
More ACS news: preclinical profile of a novel protein farnesyltransferase inhibitor, Sch-207758 Sep. 2, 1999 No Comments
Preparation, activity and use of piperidine protein farnesyltransferase inhibitors from LG Chemical Sep. 2, 1999 No Comments
RSS